Free Trial

Immunome (IMNM) Insider Trading & Ownership

$15.40
-0.39 (-2.47%)
(As of 09/17/2024 ET)

Immunome (NASDAQ:IMNM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.60%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$1.37 M
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$49,089.32
Get IMNM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Immunome stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

IMNM Insider Buying and Selling by Quarter

Immunome Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/16/2024Jean Jacques BienaimeDirectorBuy7,000$13.94$97,580.00  
8/15/2024Jack HigginsInsiderSell3,524$13.93$49,089.32  
5/21/2024Jean Jacques BienaimeDirectorBuy2,000$13.57$27,140.00  
10/2/2023Bruce TurnerInsiderBuy42,300$5.91$249,993.00  
10/2/2023Clay B SiegallCEOBuy169,204$5.91$999,995.64  
(Data available from 1/1/2013 forward)

IMNM Insider Trading Activity - Frequently Asked Questions

The list of insiders at Immunome includes Bruce Turner, Clay B Siegall, Jack Higgins, and Jean Jacques Bienaime. Learn more on insiders at IMNM.

8.60% of Immunome stock is owned by insiders. Learn more on IMNM's insider holdings.

The following insiders have purchased IMNM shares in the last 24 months: Bruce Turner ($249,993.00), Clay B Siegall ($999,995.64), and Jean Jacques Bienaime ($124,720.00).

Insiders have purchased a total of 220,504 IMNM shares in the last 24 months for a total of $1,374,708.64 bought.

The following insider sold IMNM shares in the last 24 months: Jack Higgins ($49,089.32).

Insiders have sold a total of 3,524 Immunome shares in the last 24 months for a total of $49,089.32 sold.



This page (NASDAQ:IMNM) was last updated on 9/17/2024 by MarketBeat.com Staff
From Our Partners